• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌聚糖病中心脏和呼吸系统受累情况的评估。

Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.

作者信息

Politano L, Nigro V, Passamano L, Petretta V, Comi L I, Papparella S, Nigro G, Rambaldi P F, Raia P, Pini A, Mora M, Giugliano M A, Esposito M G, Nigro G

机构信息

Dipartimento di Internistica Clinica e Sperimentale, Sezione di Cardiomiologia e Genetica Medica, Seconda Università di Napoli, I Policlinico, Piazza Miraglia, 80138, Naples, Italy.

出版信息

Neuromuscul Disord. 2001 Mar;11(2):178-85. doi: 10.1016/s0960-8966(00)00174-7.

DOI:10.1016/s0960-8966(00)00174-7
PMID:11257475
Abstract

Sarcoglycanopathies constitute a subgroup of limb-girdle recessive muscular dystrophies due to defects in sarcoglycan complex that comprises five distinct transmembrane proteins called alpha-, beta-, gamma-, delta-and epsilon-sarcoglycans. As it is well known that sarcoglycans are expressed both in heart and in skeletal muscles and a complete deficiency in delta-sarcoglycan is the cause of the Syrian hamster BIO.14 cardiomyopathy, we studied cardiac and respiratory involvement in 20 patients with sarcoglycanopathies by clinical, electrocardiographic, echocardiographic, scintigraphic and spirometric assessments. A normal heart function was found in 31.3% of all patients; a preclinical cardiomyopathy in 43.7%; an arrhythmogenic cardiomyopathy in 6.3% and initial signs of dilated cardiomyopathy in 18.7%. In one patient the data were examined retrospectively. No correlation was found between cardiac and skeletal muscle involvement. With reference to the type of sarcoglycanopathy, signs of hypoxic myocardial damage occurred in beta-, gamma- and delta-sarcoglycanopathies, while initial signs of a dilated cardiomyopathy in gamma- and delta-sarcoglycanopathies were found. A normal respiratory function was observed in 23.5% of all patients, a mild impairment in 35.4%, a moderate impairment in 29.4%, and a severe impairment in 11.7%.

摘要

肌聚糖病是肢带型隐性肌营养不良症的一个亚组,其病因是肌聚糖复合物存在缺陷,该复合物由五种不同的跨膜蛋白组成,分别称为α-、β-、γ-、δ-和ε-肌聚糖。众所周知,肌聚糖在心脏和骨骼肌中均有表达,δ-肌聚糖的完全缺失是叙利亚仓鼠BIO.14心肌病的病因,我们通过临床、心电图、超声心动图、闪烁扫描和肺活量测定评估,对20例肌聚糖病患者的心脏和呼吸受累情况进行了研究。在所有患者中,31.3%的患者心脏功能正常;43.7%的患者存在临床前心肌病;6.3%的患者存在致心律失常性心肌病;18.7%的患者出现扩张型心肌病的初始体征。1例患者的数据为回顾性检查。未发现心脏和骨骼肌受累之间存在相关性。关于肌聚糖病的类型,β-、γ-和δ-肌聚糖病出现了缺氧性心肌损伤的体征,而γ-和δ-肌聚糖病则发现了扩张型心肌病的初始体征。在所有患者中,23.5%的患者呼吸功能正常,35.4%的患者有轻度损害,29.4%的患者有中度损害,11.7%的患者有重度损害。

相似文献

1
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.肌聚糖病中心脏和呼吸系统受累情况的评估。
Neuromuscul Disord. 2001 Mar;11(2):178-85. doi: 10.1016/s0960-8966(00)00174-7.
2
Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations.β-肌聚糖突变导致心脏肌聚糖复合物破坏及严重心肌病。
J Med Genet. 2000 Feb;37(2):102-7. doi: 10.1136/jmg.37.2.102.
3
Phenotype and sarcoglycan expression in Tunisian LGMD 2C patients sharing the same del521-T mutation.具有相同del521-T突变的突尼斯LGMD 2C患者的表型和肌聚糖表达
Neuromuscul Disord. 2003 Dec;13(10):779-87. doi: 10.1016/s0960-8966(03)00136-6.
4
Sarcoglycanopathies in Dutch patients with autosomal recessive limb girdle muscular dystrophy.
J Neurol. 2000 Jul;247(7):524-9. doi: 10.1007/s004150070151.
5
Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster.δ-肌聚糖缺乏仓鼠肌肉变性的分子发病机制
Am J Pathol. 1998 Nov;153(5):1623-30. doi: 10.1016/s0002-9440(10)65751-3.
6
Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.肌聚糖的特定组装途径依赖于β-和δ-肌聚糖。
Muscle Nerve. 2004 Mar;29(3):409-19. doi: 10.1002/mus.10566.
7
Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions.肌联蛋白的分子与遗传特征:对肌聚糖-肌联蛋白相互作用的见解
Hum Mol Genet. 2000 Aug 12;9(13):2019-27. doi: 10.1093/hmg/9.13.2019.
8
A novel gamma-sarcoglycan mutation causing childhood onset, slowly progressive limb girdle muscular dystrophy.一种导致儿童期起病、缓慢进展性肢带型肌营养不良的新型γ-肌聚糖突变。
Neuromuscul Disord. 1998 Jun;8(5):305-8. doi: 10.1016/s0960-8966(98)00040-6.
9
Heart involvement in muscular dystrophies due to sarcoglycan gene mutations.
Muscle Nerve. 1999 Apr;22(4):473-9. doi: 10.1002/(sici)1097-4598(199904)22:4<473::aid-mus8>3.0.co;2-5.
10
Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2).δ-肌聚糖基因的突变是常染色体隐性肢带型肌营养不良症(LGMD2)的一种罕见病因。
Neurogenetics. 1997 May;1(1):49-58. doi: 10.1007/s100480050008.

引用本文的文献

1
Sarcospan protects against LGMD R5 via remodeling of the sarcoglycan complex composition in dystrophic mice.肌联蛋白通过重塑营养不良小鼠的肌聚糖复合物组成来预防LGMD R5。
J Clin Invest. 2025 Jun 19;135(17). doi: 10.1172/JCI187868. eCollection 2025 Sep 2.
2
Large Region of Homozygous (ROH) Identified in Indian Patients with Autosomal Recessive Limb-Girdle Muscular Dystrophy with p.Thr182Pro Variant in Gene.在患有常染色体隐性肢带型肌营养不良且基因存在p.Thr182Pro变异的印度患者中鉴定出大片纯合区域(ROH)。
Hum Mutat. 2023 Mar 28;2023:4362273. doi: 10.1155/2023/4362273. eCollection 2023.
3
Advanced Heart Failure Therapies in Neuromuscular Diseases.
神经肌肉疾病中的晚期心力衰竭治疗
Curr Treat Options Cardiovasc Med. 2024 Aug;26(8):255-270. doi: 10.1007/s11936-024-01046-2. Epub 2024 Jun 25.
4
Phenotypic Variability of LGMD 2C/R5 in a Genetically Homogenous Group of Bulgarian Muslim Roma.LGMD 2C/R5 在遗传同质的保加利亚穆斯林吉普赛人群中的表型变异性。
Genes (Basel). 2024 Aug 30;15(9):1144. doi: 10.3390/genes15091144.
5
Thrombospondin-4 deletion does not exacerbate muscular dystrophy in β-sarcoglycan-deficient and laminin α2 chain-deficient mice.TSP-4 缺失不会加重β-肌聚糖缺陷和层粘连蛋白α2 链缺陷小鼠的肌肉疾病。
Sci Rep. 2024 Jun 26;14(1):14757. doi: 10.1038/s41598-024-65473-8.
6
Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review.肌营养不良相关性扩张型心肌病终末期患者行心脏移植是否仍为禁忌?系统评价。
Int J Mol Sci. 2024 May 13;25(10):5289. doi: 10.3390/ijms25105289.
7
Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results.用 bidridistrogene xeboparvovec 进行基因治疗治疗肢带型肌营养不良症 2E/R4:1/2 期临床试验结果。
Nat Med. 2024 Jan;30(1):199-206. doi: 10.1038/s41591-023-02730-9. Epub 2024 Jan 4.
8
Modeling Sarcoglycanopathy in .建模.中的假性肌营养不良蛋白病
Int J Mol Sci. 2023 Aug 11;24(16):12707. doi: 10.3390/ijms241612707.
9
Longitudinal Analysis of Respiratory Function of Different Types of Limb Girdle Muscular Dystrophies Reveals Independent Trajectories.不同类型肢带型肌营养不良症呼吸功能的纵向分析揭示了独立的发展轨迹。
Neurol Genet. 2023 Jul 10;9(4):e200084. doi: 10.1212/NXG.0000000000200084. eCollection 2023 Aug.
10
Concept Elicitation Interviews and Conceptual Model to Understand the Patient Experience of Limb Girdle Muscular Dystrophy.概念启发访谈和概念模型,以了解肢带型肌营养不良症患者的体验。
Adv Ther. 2023 May;40(5):2296-2310. doi: 10.1007/s12325-023-02463-8. Epub 2023 Mar 14.